Insiders · Profile

Sandercock Colin

SVP, General Counsel and Sec at Cue Biopharma. Filing since 6 Jun 2019. CIK 0001724870

Company
Date
Role
Action
Shares
Amount
Of holding
5 Aug 2020
SVP, General Counsel and Sec
Sold, plan not stated
13,274
$265.48K
43.7%
4 Aug 2020
SVP, General Counsel and Sec
Sold, plan not stated
201
$4.03K
1.2%
3 Aug 2020
SVP, General Counsel and Sec
Sold, plan not stated
6,425
$128.50K
27.3%
10 Jun 2019
SVP, General Counsel and Sec
Bought
14,938
$118.46K
747%
6 Jun 2019
SVP, General Counsel and Sec
Bought
2,000
$14.20K
opened
5 decisions on file.